An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02123966

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:51.981187+00:00

Published At

2018-07-24T00:00:00+00:00

Record Updated At

2018-07-24

Results Posted At

2018-07-24

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Chronic Graft-versus-Host-Disease", "Oral Mucosal Disease Due to Graft-versus-host Disease"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-07-24"

protocolSection.identificationModule.nctId

"NCT02123966"

protocolSection.identificationModule.officialTitle

"An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease"

protocolSection.statusModule.overallStatus

"TERMINATED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2018-07-24"

Study condition terms

• Chronic Graft-versus-Host-Disease (protocolSection.conditionsModule.conditions)
• Oral Mucosal Disease Due to Graft-versus-host Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.